Author: <span>Latest News on: home</span>

YEARS of exposure to asbestos led to the death of a West Dorset man, a coroner has ruled.

John Robert Jarvis, of Glebe Court, Beaminster, died after inhaling the toxic fibres during several years of working in maintenance, an inquest at County Hall heard.Source: www.topix.com Via newsmixx: home News

The Asbestos Disease Awareness Organization (ADAO) Applauds U.S….

The Asbestos Disease Awareness Organization Applauds U.S. Senate for Passage of the Tenth Annual Resolution Establishing “National Asbestos Awareness Week” from April 1-7, 2014 )–The Asbestos Disease Awareness Organization , which combines education, …

Searching for magic bullet against cancer caused by asbestos: One step closer?

Mesothelioma is a very aggressive cancer associated with asbestos exposure, which is usually diagnosed in an advanced stage. So far no therapeutic strategy has proven effective against this deadlySource: feeds.sciencedaily.com Via newsmixx: home News

Rosetta Genomics’ Platform Predicts Bladder Cancer Progression in…

The publication in its entirety can be viewed at The study profiled and analyzed microRNA expression levels in 86 samples of non-muscle-invasive bladder cancer to identify patterns of expression that are indicative of a high probability of disease prog…

MP Barclay backs plans for victims of asbestos exposure at work to get compensation

The North East Cambs MP is supporting a new Government scheme put before the House of Commons that will allow people suffering from the incurable cancer after asbestos exposure at work but been unable to get compensation because insurers, previous empl…

Rosetta Genomics Announces Master Service Provider Agreement With a…

“We are delighted to be using our cutting-edge microRNA expertise and capabilities to assist one of the world’s leading biopharmaceutical companies to advance their research and development efforts on this important, novel therapeutic approach,” stated…

Concordia Healthcare Corp. announces FDA agreement on Special…

Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma ” TSX:CXR ) announced today that its subsidiary Pinnacle Biologics, Inc. , a biopharmaceut…